Clemensson L: Difference between revisions
From Bioblast
Beno Marija (talk | contribs) (Created page with "{{person}}") Β |
Beno Marija (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{{ | {{Person | ||
|lastname=Clemensson | |||
|firstname=Laura | |||
|institution=University of Uppsala, Department of Neuroscience | |||
Β | |||
Functional Pharmacology | |||
|address=BMC, Box 593, | |||
|area code=751 24 | |||
|city=Uppsala | |||
|country=Sweden | |||
}} | |||
{{Labelingperson}} | |||
Revision as of 11:11, 27 August 2018
| Name | Clemensson Laura, |
|---|---|
| Institution | University of Uppsala, Department of Neuroscience
Functional Pharmacology |
| Address | BMC, Box 593,, 751 24 |
| City | Uppsala |
| State/Province | |
| Country | Sweden |
| [email protected] | |
| Weblink | |
| O2k-Network Lab |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Liepinsh 2024 Br J Pharmacol | 2024 | Liepinsh E, Zvejniece L, Clemensson L, Ozola M, Vavers E, Cirule H, Korzh S, Skuja S, Groma V, Briviba M, Grinberga S, Liu W, Olszewski P, Gentreau M, Fredriksson R, Dambrova M, SchiΓΆth HB (2024) Hydroxymethylglutaryl-CoA reductase activity is essential for mitochondrial Ξ²-oxidation of fatty acids to prevent lethal accumulation of long-chain acylcarnitines in the mouse liver. Br J Pharmacol [Epub ahead of print]. https://doi.org/10.1111/bph.16363 |
Abstracts
| Published | Reference | |
|---|---|---|
| Clemensson 2018 MiP2018 | 2018 |  |
